Global Remicade Biosimilar Market Growth 2018-2023

Publisher Name :
Date: 22-Oct-2018
No. of pages: 138

Biosimilar can be defined as a type of biological product that is highly similar to an already FDA approved drug, known as reference biological product.

Over the next five years, LPI(LP Information) projects that Remicade Biosimilar will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Remicade Biosimilar market for 2018-2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Remicade Biosimilar market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

- 100mg/10ml

- 500mg/50ml

Segmentation by application:

- Blood Disorders

- Oncology Diseases

This report also splits the market by region:

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Spain

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

- Synthon Pharmaceuticals

- LG Life Sciences

- Novartis (Sandoz)

- Celltrion

- Biocon

- Hospira

- Merck Serono (Merck Group)

- Biogen idec Inc.

- Genentech (Roche Group)

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

- To study and analyze the global Remicade Biosimilar consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.

- To understand the structure of Remicade Biosimilar market by identifying its various subsegments.

- Focuses on the key global Remicade Biosimilar manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Remicade Biosimilar with respect to individual growth trends, future prospects, and their contribution to the total market.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- To project the consumption of Remicade Biosimilar submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

Global Remicade Biosimilar Market Growth 2018-2023

Table of Contents

2018-2023 Global Remicade Biosimilar Consumption Market Report

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Remicade Biosimilar Consumption 2013-2023
2.1.2 Remicade Biosimilar Consumption CAGR by Region
2.2 Remicade Biosimilar Segment by Type
2.2.1 100mg/10ml
2.2.2 500mg/50ml
2.3 Remicade Biosimilar Consumption by Type
2.3.1 Global Remicade Biosimilar Consumption Market Share by Type (2013-2018)
2.3.2 Global Remicade Biosimilar Revenue and Market Share by Type (2013-2018)
2.3.3 Global Remicade Biosimilar Sale Price by Type (2013-2018)
2.4 Remicade Biosimilar Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.5 Remicade Biosimilar Consumption by Application
2.5.1 Global Remicade Biosimilar Consumption Market Share by Application (2013-2018)
2.5.2 Global Remicade Biosimilar Value and Market Share by Application (2013-2018)
2.5.3 Global Remicade Biosimilar Sale Price by Application (2013-2018)

3 Global Remicade Biosimilar by Players
3.1 Global Remicade Biosimilar Sales Market Share by Players
3.1.1 Global Remicade Biosimilar Sales by Players (2016-2018)
3.1.2 Global Remicade Biosimilar Sales Market Share by Players (2016-2018)
3.2 Global Remicade Biosimilar Revenue Market Share by Players
3.2.1 Global Remicade Biosimilar Revenue by Players (2016-2018)
3.2.2 Global Remicade Biosimilar Revenue Market Share by Players (2016-2018)
3.3 Global Remicade Biosimilar Sale Price by Players
3.4 Global Remicade Biosimilar Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Remicade Biosimilar Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Remicade Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Remicade Biosimilar by Regions
4.1 Remicade Biosimilar by Regions
4.1.1 Global Remicade Biosimilar Consumption by Regions
4.1.2 Global Remicade Biosimilar Value by Regions
4.2 Americas Remicade Biosimilar Consumption Growth
4.3 APAC Remicade Biosimilar Consumption Growth
4.4 Europe Remicade Biosimilar Consumption Growth
4.5 Middle East & Africa Remicade Biosimilar Consumption Growth

5 Americas
5.1 Americas Remicade Biosimilar Consumption by Countries
5.1.1 Americas Remicade Biosimilar Consumption by Countries (2013-2018)
5.1.2 Americas Remicade Biosimilar Value by Countries (2013-2018)
5.2 Americas Remicade Biosimilar Consumption by Type
5.3 Americas Remicade Biosimilar Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Remicade Biosimilar Consumption by Countries
6.1.1 APAC Remicade Biosimilar Consumption by Countries (2013-2018)
6.1.2 APAC Remicade Biosimilar Value by Countries (2013-2018)
6.2 APAC Remicade Biosimilar Consumption by Type
6.3 APAC Remicade Biosimilar Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 Europe
7.1 Europe Remicade Biosimilar by Countries
7.1.1 Europe Remicade Biosimilar Consumption by Countries (2013-2018)
7.1.2 Europe Remicade Biosimilar Value by Countries (2013-2018)
7.2 Europe Remicade Biosimilar Consumption by Type
7.3 Europe Remicade Biosimilar Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Remicade Biosimilar by Countries
8.1.1 Middle East & Africa Remicade Biosimilar Consumption by Countries (2013-2018)
8.1.2 Middle East & Africa Remicade Biosimilar Value by Countries (2013-2018)
8.2 Middle East & Africa Remicade Biosimilar Consumption by Type
8.3 Middle East & Africa Remicade Biosimilar Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.2 Remicade Biosimilar Distributors
10.3 Remicade Biosimilar Customer

11 Global Remicade Biosimilar Market Forecast
11.1 Global Remicade Biosimilar Consumption Forecast (2018-2023)
11.2 Global Remicade Biosimilar Forecast by Regions
11.2.1 Global Remicade Biosimilar Forecast by Regions (2018-2023)
11.2.2 Global Remicade Biosimilar Value Forecast by Regions (2018-2023)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Remicade Biosimilar Forecast by Type
11.8 Global Remicade Biosimilar Forecast by Application

12 Key Players Analysis
12.1 Synthon Pharmaceuticals
12.1.1 Company Details
12.1.2 Remicade Biosimilar Product Offered
12.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.1.4 Main Business Overview
12.1.5 Synthon Pharmaceuticals News
12.2 LG Life Sciences
12.2.1 Company Details
12.2.2 Remicade Biosimilar Product Offered
12.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.2.4 Main Business Overview
12.2.5 LG Life Sciences News
12.3 Novartis (Sandoz)
12.3.1 Company Details
12.3.2 Remicade Biosimilar Product Offered
12.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.3.4 Main Business Overview
12.3.5 Novartis (Sandoz) News
12.4 Celltrion
12.4.1 Company Details
12.4.2 Remicade Biosimilar Product Offered
12.4.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.4.4 Main Business Overview
12.4.5 Celltrion News
12.5 Biocon
12.5.1 Company Details
12.5.2 Remicade Biosimilar Product Offered
12.5.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.5.4 Main Business Overview
12.5.5 Biocon News
12.6 Hospira
12.6.1 Company Details
12.6.2 Remicade Biosimilar Product Offered
12.6.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.6.4 Main Business Overview
12.6.5 Hospira News
12.7 Merck Serono (Merck Group)
12.7.1 Company Details
12.7.2 Remicade Biosimilar Product Offered
12.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.7.4 Main Business Overview
12.7.5 Merck Serono (Merck Group) News
12.8 Biogen idec Inc.
12.8.1 Company Details
12.8.2 Remicade Biosimilar Product Offered
12.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.8.4 Main Business Overview
12.8.5 Biogen idec Inc. News
12.9 Genentech (Roche Group)
12.9.1 Company Details
12.9.2 Remicade Biosimilar Product Offered
12.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
12.9.4 Main Business Overview
12.9.5 Genentech (Roche Group) News

13 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Remicade Biosimilar
Table Product Specifications of Remicade Biosimilar
Figure Remicade Biosimilar Report Years Considered
Figure Market Research Methodology
Figure Global Remicade Biosimilar Consumption Growth Rate 2013-2023 (K Units)
Figure Global Remicade Biosimilar Value Growth Rate 2013-2023 ($ Millions)
Table Remicade Biosimilar Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of 100mg/10ml
Table Major Players of 100mg/10ml
Figure Product Picture of 500mg/50ml
Table Major Players of 500mg/50ml
Table Global Consumption Sales by Type (2013-2018)
Table Global Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Figure Global Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Table Global Remicade Biosimilar Revenue by Type (2013-2018) ($ million)
Table Global Remicade Biosimilar Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Remicade Biosimilar Value Market Share by Type (2013-2018)
Table Global Remicade Biosimilar Sale Price by Type (2013-2018)
Figure Remicade Biosimilar Consumed in Blood Disorders
Figure Global Remicade Biosimilar Market: Blood Disorders (2013-2018) (K Units)
Figure Global Remicade Biosimilar Market: Blood Disorders (2013-2018) ($ Millions)
Figure Global Blood Disorders YoY Growth ($ Millions)
Figure Remicade Biosimilar Consumed in Oncology Diseases
Figure Global Remicade Biosimilar Market: Oncology Diseases (2013-2018) (K Units)
Figure Global Remicade Biosimilar Market: Oncology Diseases (2013-2018) ($ Millions)
Figure Global Oncology Diseases YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Figure Global Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Table Global Remicade Biosimilar Value by Application (2013-2018)
Table Global Remicade Biosimilar Value Market Share by Application (2013-2018)
Figure Global Remicade Biosimilar Value Market Share by Application (2013-2018)
Table Global Remicade Biosimilar Sale Price by Application (2013-2018)
Table Global Remicade Biosimilar Sales by Players (2016-2018) (K Units)
Table Global Remicade Biosimilar Sales Market Share by Players (2016-2018)
Figure Global Remicade Biosimilar Sales Market Share by Players in 2016
Figure Global Remicade Biosimilar Sales Market Share by Players in 2017
Table Global Remicade Biosimilar Revenue by Players (2016-2018) ($ Millions)
Table Global Remicade Biosimilar Revenue Market Share by Players (2016-2018)
Figure Global Remicade Biosimilar Revenue Market Share by Players in 2016
Figure Global Remicade Biosimilar Revenue Market Share by Players in 2017
Table Global Remicade Biosimilar Sale Price by Players (2016-2018)
Figure Global Remicade Biosimilar Sale Price by Players in 2017
Table Global Remicade Biosimilar Manufacturing Base Distribution and Sales Area by Players
Table Players Remicade Biosimilar Products Offered
Table Remicade Biosimilar Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Remicade Biosimilar Consumption by Regions 2013-2018 (K Units)
Table Global Remicade Biosimilar Consumption Market Share by Regions 2013-2018
Figure Global Remicade Biosimilar Consumption Market Share by Regions 2013-2018
Table Global Remicade Biosimilar Value by Regions 2013-2018 ($ Millions)
Table Global Remicade Biosimilar Value Market Share by Regions 2013-2018
Figure Global Remicade Biosimilar Value Market Share by Regions 2013-2018
Figure Americas Remicade Biosimilar Consumption 2013-2018 (K Units)
Figure Americas Remicade Biosimilar Value 2013-2018 ($ Millions)
Figure APAC Remicade Biosimilar Consumption 2013-2018 (K Units)
Figure APAC Remicade Biosimilar Value 2013-2018 ($ Millions)
Figure Europe Remicade Biosimilar Consumption 2013-2018 (K Units)
Figure Europe Remicade Biosimilar Value 2013-2018 ($ Millions)
Figure Middle East & Africa Remicade Biosimilar Consumption 2013-2018 (K Units)
Figure Middle East & Africa Remicade Biosimilar Value 2013-2018 ($ Millions)
Table Americas Remicade Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Americas Remicade Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Americas Remicade Biosimilar Consumption Market Share by Countries in 2017
Table Americas Remicade Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Americas Remicade Biosimilar Value Market Share by Countries (2013-2018)
Figure Americas Remicade Biosimilar Value Market Share by Countries in 2017
Table Americas Remicade Biosimilar Consumption by Type (2013-2018) (K Units)
Table Americas Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Figure Americas Remicade Biosimilar Consumption Market Share by Type in 2017
Table Americas Remicade Biosimilar Consumption by Application (2013-2018) (K Units)
Table Americas Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Figure Americas Remicade Biosimilar Consumption Market Share by Application in 2017
Figure United States Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure United States Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Canada Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Canada Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Mexico Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Mexico Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Table APAC Remicade Biosimilar Consumption by Countries (2013-2018) (K Units)
Table APAC Remicade Biosimilar Consumption Market Share by Countries (2013-2018)
Figure APAC Remicade Biosimilar Consumption Market Share by Countries in 2017
Table APAC Remicade Biosimilar Value by Countries (2013-2018) ($ Millions)
Table APAC Remicade Biosimilar Value Market Share by Countries (2013-2018)
Figure APAC Remicade Biosimilar Value Market Share by Countries in 2017
Table APAC Remicade Biosimilar Consumption by Type (2013-2018) (K Units)
Table APAC Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Figure APAC Remicade Biosimilar Consumption Market Share by Type in 2017
Table APAC Remicade Biosimilar Consumption by Application (2013-2018) (K Units)
Table APAC Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Figure APAC Remicade Biosimilar Consumption Market Share by Application in 2017
Figure China Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure China Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Japan Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Japan Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Korea Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Korea Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure India Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure India Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Australia Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Australia Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Table Europe Remicade Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Europe Remicade Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Europe Remicade Biosimilar Consumption Market Share by Countries in 2017
Table Europe Remicade Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Europe Remicade Biosimilar Value Market Share by Countries (2013-2018)
Figure Europe Remicade Biosimilar Value Market Share by Countries in 2017
Table Europe Remicade Biosimilar Consumption by Type (2013-2018) (K Units)
Table Europe Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Figure Europe Remicade Biosimilar Consumption Market Share by Type in 2017
Table Europe Remicade Biosimilar Consumption by Application (2013-2018) (K Units)
Table Europe Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Figure Europe Remicade Biosimilar Consumption Market Share by Application in 2017
Figure Germany Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Germany Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure France Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure France Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure UK Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure UK Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Italy Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Italy Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Russia Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Russia Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Spain Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Spain Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Remicade Biosimilar Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Remicade Biosimilar Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Remicade Biosimilar Consumption Market Share by Countries in 2017
Table Middle East & Africa Remicade Biosimilar Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Remicade Biosimilar Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Remicade Biosimilar Value Market Share by Countries in 2017
Table Middle East & Africa Remicade Biosimilar Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Remicade Biosimilar Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Remicade Biosimilar Consumption Market Share by Type in 2017
Table Middle East & Africa Remicade Biosimilar Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Remicade Biosimilar Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Remicade Biosimilar Consumption Market Share by Application in 2017
Figure Egypt Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Egypt Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure South Africa Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure South Africa Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Israel Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Israel Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure Turkey Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure Turkey Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Remicade Biosimilar Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Remicade Biosimilar Value Growth 2013-2018 ($ Millions)
Table Remicade Biosimilar Distributors List
Table Remicade Biosimilar Customer List
Figure Global Remicade Biosimilar Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Remicade Biosimilar Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Remicade Biosimilar Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Remicade Biosimilar Consumption Market Forecast by Regions
Table Global Remicade Biosimilar Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Remicade Biosimilar Value Market Share Forecast by Regions
Figure Americas Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Americas Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure APAC Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure APAC Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Europe Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Europe Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Middle East & Africa Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Middle East & Africa Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure United States Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure United States Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Canada Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Canada Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Mexico Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Mexico Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Brazil Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Brazil Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure China Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure China Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Japan Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Japan Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Korea Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Korea Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Southeast Asia Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Southeast Asia Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure India Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure India Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Australia Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Australia Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Germany Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Germany Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure France Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure France Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure UK Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure UK Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Italy Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Italy Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Russia Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Russia Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Spain Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Spain Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Egypt Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Egypt Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure South Africa Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure South Africa Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Israel Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Israel Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure Turkey Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure Turkey Remicade Biosimilar Value 2018-2023 ($ Millions)
Figure GCC Countries Remicade Biosimilar Consumption 2018-2023 (K Units)
Figure GCC Countries Remicade Biosimilar Value 2018-2023 ($ Millions)
Table Global Remicade Biosimilar Consumption Forecast by Type (2018-2023) (K Units)
Table Global Remicade Biosimilar Consumption Market Share Forecast by Type (2018-2023)
Table Global Remicade Biosimilar Value Forecast by Type (2018-2023) ($ Millions)
Table Global Remicade Biosimilar Value Market Share Forecast by Type (2018-2023)
Table Global Remicade Biosimilar Consumption Forecast by Application (2018-2023) (K Units)
Table Global Remicade Biosimilar Consumption Market Share Forecast by Application (2018-2023)
Table Global Remicade Biosimilar Value Forecast by Application (2018-2023) ($ Millions)
Table Global Remicade Biosimilar Value Market Share Forecast by Application (2018-2023)
Table Synthon Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Synthon Pharmaceuticals Remicade Biosimilar Market Share (2016-2018)
Table LG Life Sciences Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure LG Life Sciences Remicade Biosimilar Market Share (2016-2018)
Table Novartis (Sandoz) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis (Sandoz) Remicade Biosimilar Market Share (2016-2018)
Table Celltrion Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Celltrion Remicade Biosimilar Market Share (2016-2018)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biocon Remicade Biosimilar Market Share (2016-2018)
Table Hospira Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Hospira Remicade Biosimilar Market Share (2016-2018)
Table Merck Serono (Merck Group) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Serono (Merck Group) Remicade Biosimilar Market Share (2016-2018)
Table Biogen idec Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Biogen idec Inc. Remicade Biosimilar Market Share (2016-2018)
Table Genentech (Roche Group) Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Genentech (Roche Group) Remicade Biosimilar Market Share (2016-2018)
  • Global Gastroesophageal Reflux Disease Therapeutics Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Gastroesophageal Reflux Disease Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Gastroesophageal Reflux Disease Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Gastroesophageal Reflux Disease Therapeutics market size by analyzing historical data and future prospect.......
  • Global Cytomegalovirus Therapeutics Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Cytomegalovirus Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Cytomegalovirus Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cytomegalovirus Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the pr......
  • Global Zinc Drops Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Zinc Drops market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Zinc Drops volume and value at global level, regional level and company level. From a global perspective, this report represents overall Zinc Drops market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Z......
  • Global Afinitor Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Afinitor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Afinitor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Afinitor market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Afinito......
  • Global Coagulation Factor VIIa Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Coagulation Factor VIIa market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Coagulation Factor VIIa volume and value at global level, regional level and company level. From a global perspective, this report represents overall Coagulation Factor VIIa market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, appar......
  • Global Raubasine Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Raubasine market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Raubasine volume and value at global level, regional level and company level. From a global perspective, this report represents overall Raubasine market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Raub......
  • Global Vegan Protein Powder Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Vegan Protein Powder market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Vegan Protein Powder volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vegan Protein Powder market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consu......
  • Global Doxazosin Mesylate Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Doxazosin Mesylate market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Doxazosin Mesylate volume and value at global level, regional level and company level. From a global perspective, this report represents overall Doxazosin Mesylate market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption......
  • Global Propofol Medium and Long Chain Fat Emulsion Injection Market Professional Survey Report 2019
    Published: 18-Oct-2019        Price: US 3500 Onwards        Pages: 102
    The global Propofol Medium and Long Chain Fat Emulsion Injection market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Propofol Medium and Long Chain Fat Emulsion Injection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Propofol Medium and Long Chain Fat Emulsion Injection market size by analyzing historical ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs